Fanapt Sanctioned for Schizophrenia

May 7 (HealthDay News) -- A new pill to treat adults with schizophrenia has been approved by the U.S. Food and Drug Administration.

Fanapt (iloperidone), which belongs to the atypical antipsychotic class of drugs, is not approved for patients with dementia-related psychosis, United Press International reported.

The FDA ordered that Fanapt carry a boxed warning about the increased risk of death associated with off-label use of the drug to treat behavioral problems in patients with dementia-related psychosis.

Fanapt is made by Patheon Inc., in Ontario, Canada, for Vanda Pharmaceuticals Inc., of Rockville, Md., UPI reported.


Connect with Us
Follow Our Pins

Yummy recipes, DIY projects, home decor, fashion and more curated by iVillage staffers.

Follow Our Tweets

The very dirty truth about fashion internships... DUN DUN @srslytheshow http://t.co/wfewf

On Instagram

Behind-the-scenes pics from iVillage.

Best of the Web